Research summary ·
Percutaneous microwave ablation of hyperfunctioning parathyroid lesions under multiparametric ultrasound guidance for primary hyperparathyroidism: a systematic review and meta-analysis.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This review looked at a treatment for primary hyperparathyroidism. The treatment uses heat from microwaves. A thin needle goes in through the skin. The heat targets overactive spots in the parathyroid glands. Doctors guide the needle with several kinds of ultrasound scans. The team pooled 9 groups of people, 355 people in all. All were cohort studies, which follow people after a treatment.
What they found
The treatment could be done as planned in every person. The review gave rates of people judged free of the disease. These rates were checked at 6 months and at 12 months. The rate was lower at 12 months than at 6 months. It was lower again at the last check. Blood calcium and hormone levels dropped clearly. Blood phosphorus went up at every time point. Some people had problems after the treatment. The most common were a hoarse voice and low calcium that passed. Lasting harm to a voice nerve was rare.
What it means for patients
The authors say this heat treatment may be an option for some people. They mean people with this disease who are carefully chosen. The method works through the skin with a needle. The authors call the blood test gains up to mid-term acceptable. They judge the safety record as one people can bear.
Why it is not certain yet
The review pooled only 9 groups with 355 people. Results reach only mid-term, so later effects are not known. The rate of people free of the disease fell at later checks. The abstract does not give results for a comparison group. A review can only be as good as the studies in it.
Source
Percutaneous microwave ablation of hyperfunctioning parathyroid lesions under multiparametric ultrasound guidance for primary hyperparathyroidism: a systematic review and meta-analysis.
PubMed · PMID 42835108We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Hyperparathyroidism publications